Your browser doesn't support javascript.
loading
Disease-modifying therapy for multiple sclerosis. / Behandling som begrenser multippel sklerose.
Tidsskr Nor Laegeforen ; 141(8)2021 05 25.
Article en En, Nor | MEDLINE | ID: mdl-34047171
High-efficacy therapy from the time of diagnosis substantially improves the prognosis for multiple sclerosis. The national guidelines on MS nevertheless recommend less effective therapy for many patients, and must be updated in pace with medical advances. We consider in the following how multiple sclerosis should be treated.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Guideline Límite: Humans Idioma: En / Nor Revista: Tidsskr Nor Laegeforen Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Guideline Límite: Humans Idioma: En / Nor Revista: Tidsskr Nor Laegeforen Año: 2021 Tipo del documento: Article